SBI-993 manufacturers
- SBI-477 analog
-
- $70.00
-
2026-07-30
- CAS:2073059-56-8
- Purity: 99.82%
- Supply Ability: 10g
|
| | SBI-993 Basic information |
| Product Name: | SBI-993 | | Synonyms: | SBI-993;N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-4-(2-morpholin-4-yl-2-oxoethoxy)benzamide;SBI-993;SBI 993;SBI993;Benzamide, N-[4-(4-methoxyphenyl)-2-thiazolyl]-4-[2-(4-morpholinyl)-2-oxoethoxy]-;SBI993, 10 mM in DMSO;N-[4-(4-Methoxyphenyl)-2-thiazolyl]-4-[2-(4-morpholinyl)-2-oxoethoxy]benzamide | | CAS: | 2073059-56-8 | | MF: | C23H23N3O5S | | MW: | 453.51 | | EINECS: | | | Product Categories: | | | Mol File: | 2073059-56-8.mol |  |
| | SBI-993 Chemical Properties |
| | SBI-993 Usage And Synthesis |
| Uses | SBI-477 (compound 41) analog inhibits intracellular lipid accumulation, increase celluar glucose uptake[1]. | | References | [1] Daniel Kelly, et al Modulators of myocyte lipid accumulation and insulin resistance and methods of use thereof. United States, WO2017019772A1. 2017-02-02 |
| | SBI-993 Preparation Products And Raw materials |
|